Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: A meta-analysis

Thrombosis Research

Volumn 134, Issue 6, 2014, Pages 1241-1248

  Wang, Jiarong ^a   Wang, Chengdi ^a   Chen, Nan ^a   Shu, Chi ^a   Guo, Xiaojiang ^a   He, Yazhou ^a   Zhou, Yanhong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

4G 5G polymorphism; Genetic susceptibility; Meta analysis; PAI 1; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; GENETIC MARKER; SERPINE1 PROTEIN, HUMAN;

ARTICLE; ASIAN; CAUCASIAN; DEEP VEIN THROMBOSIS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; META ANALYSIS; NEOPLASM; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84915759399     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.09.035     Document Type: Article

References (61)

1. W.F. Baker Jr. Diagnosis of deep venous thrombosis and pulmonary embolism Med Clin North Am 82 3 1998 459 476 10.1016/S0025-7125(05)70005-5
2. J.A. Heit The epidemiology of venous thromboembolism in the community Arterioscler Thromb Vasc Biol 28 3 2008 370 372 10.1161/atvbaha.108.162545
3. R.H. White The Epidemiology of Venous Thromboembolism Circulation 107 23 suppl 1 2003 I-4 I-8 10.1161/01.cir.0000078468.11849.66
4. P.A. Kyrle, and S. Eichinger Deep vein thrombosis Lancet 365 9465 2005 1163 1174 10.1016/s0140-6736(05)71880-8
5. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 6 2000 809 815
6. M.J. Jang, Y.J. Jeon, W.I. Choi, Y.S. Choi, S.Y. Kim, and S.Y. Chong The 677C > T mutation of the MTHFR gene increases the risk of venous thromboembolism in Koreans and a meta-analysis from Asian population Clin Appl Thromb Hemost 19 3 2013 309 314 10.1177/1076029612436677
7. X. Zhou, W. Qian, J. Li, P. Zhang, Z. Yang, and W. Chen Who are at risk for thromboembolism after arthroplasty? A systematic review and meta-analysis Thromb Res 132 5 2013 531 536 10.1016/j.thromres.2013.09.005
8. M.S. Pepper Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis Arterioscler Thromb Vasc Biol 21 7 2001 1104 1117
9. S. Ulisse, E. Baldini, S. Sorrenti, and M. D'Armiento The urokinase plasminogen activator system: a target for anti-cancer therapy Curr Cancer Drug Targets 9 1 2009 32 71
10. D. Barcellona, L. Fenu, C. Cauli, G. Pisu, and F. Marongiu Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis Thromb Haemost 90 6 2003 1061 1064 10.1267/THRO03061061
11. F. Burzotta, A. Di Castelnuovo, C. Amore, A. D'Orazio, R. Di Bitondo, and M.B. Donati 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction Thromb Haemost 79 2 1998 354 358
12. P. Eriksson, B. Kallin, F.M. van 't Hooft, P. Bavenholm, and A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci U S A 92 6 1995 1851 1855
13. A. Shelest, M.A. Matveeva, L.V. Popova, L.I. Patrushev, E.G. Shuganov, and T.Y. Gneusheva Plasminogen activator inhibitor type 1 (PAI-1) level and activity at patients with PAI-1 polymorphism J Thromb Haemost 11 2013 1173
14. M.L. Varela, Y.P. Adamczuk, R.R. Forastiero, M.E. Martinuzzo, G.S. Cerrato, and G. Pombo Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism Thromb Res 104 5 2001 317 324
15. N. Akar, E. Yilmaz, E. Akar, F. Avcu, A. Yalcin, and S. Cin Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A Thromb Res 97 4 2000 227 230
16. M.S. Akhter, A. Biswas, R. Ranjan, A. Meena, B.K. Yadav, and A. Sharma Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis Clin Appl Thromb Hemost 16 2 2010 184 188 10.1177/1076029609333673
17. Z. Alfirevic, A.M. Simundic, N. Nikolac, N. Sobocan, I. Alfirevic, and M. Stefanovic Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-15G/4G polymorphism in patients with venous thromboembolism: Croatian case-control study Biochem Med 20 2 2010 229 235
18. S. Arslan, S. Manduz, K. Epozturk, O. Karahan, and I. Akkurt Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases Mol Biol Rep 38 4 2011 2395 2400 10.1007/s11033-010-0373-y
19. M. Bedencic, M. Bozic, P. Peternel, and M. Stegnar Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia Pathophysiol Haemost Thromb 36 2 2008 58 63 10.1159/000173722
20. Y.L. Chen, J.X. Zhang, P.X. Wang, R.Z. Cui, F.M. Zhao, and Y.M. Mao Association of 4G/5G polymorphism in PAI1 promoter with PAI1 level in deep vein thrombosis Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22 6 2005 624 627
21. A.E. Tsantes, G.K. Nikolopoulos, P.G. Bagos, E. Rapti, G. Mantzios, and V. Kapsimali Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis Thromb Haemost 97 6 2007 907 913
22. E. Zintzaras, and J. Lau Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches J Clin Epidemiol 61 7 2008 634 645 10.1016/j.jclinepi.2007.12.011
23. E. Zintzaras, and J.P. Ioannidis Heterogeneity testing in meta-analysis of genome searches Genet Epidemiol 28 2 2005 123 137 10.1002/gepi.20048
24. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 557 560 10.1136/bmj.327.7414.557
25. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 4 1959 719 748
26. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188 10.1016/0197-2456(86)90046-2
27. M. Egger, G.D. Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 1997 629 634 10.1136/bmj.315.7109.629
28. M. Cushman, L.H. Kuller, R. Prentice, R.J. Rodabough, B.M. Psaty, and R.S. Stafford Estrogen plus progestin and risk of venous thrombosis JAMA 292 13 2004 1573 1580 10.1001/jama.292.13.1573
29. A. Eroglu, A. Ulu, and N. Akar Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis J Thromb Thrombolysis 22 2 2006 111 112 10.1007/s11239-006-9054-z
30. G. Espinosa, J. Font, D. Tassies, A. Vidaller, R. Deulofeu, and A. Lopez-Soto Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin Am J Med 112 1 2002 37 43
31. F. Ferrara, F. Meli, F. Raimondi, S. Montalto, V. Cospite, and G. Novo The association between the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor-1 gene and extension of postsurgical calf vein thrombosis Blood Coagul Fibrinolysis 24 3 2013 237 242 10.1097/MBC.0b013e328359f618
32. A.R. Folsom, M. Cushman, S.R. Heckbert, W.D. Rosamond, and N. Aleksic Prospective study of fibrinolytic markers and venous thromboembolism J Clin Epidemiol 56 6 2003 598 603
33. N. Grubic, M. Stegnar, P. Peternel, A. Kaider, and B.R. Binder A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis Thromb Res 84 6 1996 431 443
34. N.S. Hasan, H.G. El Din, M.A.E.K. Awad, and H.A. Aisha Genetic mutation in thrombophilic Egyptian patients J Med Sci 6 4 2006 591 596
35. R. Junker, D.G. Nabavi, E. Wolff, P. Ludemann, U. Nowak-Gottl, and M. Kase Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers Thromb Haemost 80 4 1998 706 707
36. E. Kupeli, H. Verdi, A. Simsek, F.B. Atac, and F.O. Eyuboglu Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis Clin Appl Thromb Hemost 17 6 2011 E87 E94 10.1177/1076029610385224
37. V. Le Cam-Duchez, J.Y. Borg, C. Saladin-Thiron, A. Bauters, B. Jude, and P.E. Morange ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: A study of 180 homozygotes for the Factor V Leiden mutation Br J Haematol 135 5 2006 697 702
38. C. Lichy, M. Kloss, P. Reismann, J. Genius, A. Grau, and K. Reuner No evidence for plasminogen activator inhibitor 1 4G/4G genotype as risk factor for cerebral venous thrombosis J Neurol 254 8 2007 1124 1125 10.1007/s00415-006-0417-3
39. A. Mansilha, F. Araujo, M. Severo, S.M. Sampaio, T. Toledo, and I. Henriques The association between the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor-1 gene and deep venous thrombosis in young people Phlebology 20 1 2005 48 52
40. L. Meglic, M. Stegnar, T. Milanez, M. Bozic, B. Peterlin, and P. Peternel Factor V Leiden, prothrombin 20210G - > A, methylenetetrahydrofolate reductase 677C - > T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism Eur J Obstet Gynecol Reprod Biol 111 2 2003 157 163
41. P.E. Morange, M. Henry, D. Tregouet, B. Granel, M.F. Aillaud, and M.C. Alessi The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers Arterioscler Thromb Vasc Biol 20 5 2000 1387 1391
42. I.K. Oguzulgen, E. Yilmaz, S. Demirtas, F.O. Erkekol, N. Ekim, and N. Demir The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism Clin Appl Thromb Hemost 15 1 2009 73 77 10.1177/1076029607305110
43. E. Onur, A.T. Kurdal, B. Tugrul, I. Iskesen, P. Dundar, and F. Taneli Is genetic screening necessary for determining the possibility of venous thromboembolism in cancer patients? Med Princ Pract 21 2 2012 160 163 10.1159/000333394
44. M. Ozkan, S. Sivgin, I. Kocyigit, F. Emirogullari, M. Dikilitas, and L. Kaynar Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients? Asia Pac J Clin Oncol 8 3 2012 e34 e41 10.1111/j.1743-7563.2012.01536.x
45. P.M. Ridker, C.H. Hennekens, K. Lindpaintner, M.J. Stampfer, and J.P. Miletich Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men Circulation 95 1 1997 59 62
46. M. Ringelstein, A. Jung, K. Berger, M. Stoll, K. Madlener, and C. Klotzsch Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults J Neurol 259 11 2012 2287 2292 10.1007/s00415-012-6477-7
47. J. Ringwald, A. Berger, W. Adler, C. Kraus, and R.P. Pitto Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study Clin Orthop Relat Res 467 6 2009 1507 1515 10.1007/s11999-008-0498-7
48. M.T. Sartori, C. Danesin, G. Saggiorato, D. Tormene, P. Simioni, and L. Spiezia The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia Clin Appl Thromb Hemost 9 4 2003 299 307
49. M.T. Sartori, B. Wiman, S. Vettore, F. Dazzi, A. Girolami, and G.M. Patrassi 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis Thromb Haemost 80 6 1998 956 960
50. J.F. Schenk, B. Stephan, S. Zewinger, T. Speer, and G. Pindur Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion Clin Hemorheol Microcirc 39 1-4 2008 329 332
51. R. Segui, A. Estelles, Y. Mira, F. Espana, P. Villa, and C. Falco PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects Br J Haematol 111 1 2000 122 128
52. M. Stegnar, P. Uhrin, P. Peternel, A. Mavri, B. Salobir-Pajnic, and J. Stare The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism Thromb Haemost 79 5 1998 975 979
53. D. Tassies, G. Espinosa, F.J. Munoz-Rodriguez, C. Freire, R. Cervera, and J. Monteagudo The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome Arthritis Rheum 43 10 2000 2349 2358 10.1002/1529-0131(200010)43:10<2349::aid-anr24>3.0.co;2-j
54. J.M. Visanji, J. Seargent, D. Tahri, S.A. Croft, M. Makris, and F.E. Preston Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden Br J Haematol 110 1 2000 135 138
55. H.M. Zhou, P. Yang, C.Z. Feng, S.X. Ma, and Y.H. Yin A study on the relationship of the plasminogen activator inhibitor (PAI-1) and its polymorphism of 4G/5G in promotor region with deep vein thrombosis after operation J Guiyang Med Coll 2005 01
56. M. Verschuur, A. Jellema, E.M. Bladbjerg, M. Feskens EJ, R.P. Mensink, and L. Møller The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals Atherosclerosis 181 2 2005 275 284 10.1016/j.atherosclerosis.2005.01.036
57. M.D.I. Vergouwen, C.J.M. Frijns, Y.B.W.E.M. Roos, G.J.E. Rinkel, F. Baas, and M. Vermeulen Plasminogen Activator Inhibitor-1 4G Allele in the 4G/5G Promoter Polymorphism Increases the Occurrence of Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage Stroke 35 6 2004 1280 1283 10.1161/01.STR.0000128707.48644.7e
58. C.N. Bagot, and R. Arya Virchow and his triad: a question of attribution Br J Haematol 143 2 2008 180 190 10.1111/j.1365-2141.2008.07323.x
59. C.A. Kiire, and N.V. Chong Managing retinal vein occlusion BMJ (Online) 344 7845 2012 37 43
60. R. Gohil, G. Peck, and P. Sharma The genetics of venous thromboembolism: A meta-analysis involving ∼ 120,000 cases and 180,000 controls Thromb Haemost 102 2 2009 360 370
61. A.E. Tsantes, G.K. Nikolopoulos, P.G. Bagos, S. Bonovas, P. Kopterides, and G. Vaiopoulos The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk Thromb Res 122 6 2008 736 742 10.1016/j.thromres.2007.09.005